Antihyperglycemic activity of trigonelline and sitagliptin in nicotinamide-streptozotocin induced diabetes in Wistar rats
Authors:
- Hemant V. KambleHKHemant V. Kamble
- Subhash L. BodhankarSBSubhash L. Bodhankar
- 1 July 2013
- journal article
- Published by Elsevier in Biomedicine & Aging Pathology
- Vol. 3 (3) , 125-130
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Simultaneous quantitation of metformin and sitagliptin from mouse and human dried blood spots using laser diode thermal desorption tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2011
- Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetesRegulatory Peptides, 2011
- Renal function in diabetic nephropathyWorld Journal of Diabetes, 2010
- Can primary care professionals’ adherence to Evidence Based Medicine tools improve quality of care in Type 2 diabetes mellitus? A systematic reviewDiabetes Research and Clinical Practice, 2009
- Incretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetesArchives of Endocrinology and Metabolism, 2008
- Biology of Incretins: GLP-1 and GIPGastroenterology, 2007
- Disposition of the Dipeptidyl Peptidase 4 Inhibitor Sitagliptin in Rats and DogsDrug Metabolism and Disposition, 2007
- Review of sitagliptin phosphate: a novel treatment for type 2 diabetesVascular Health and Risk Management, 2007
- Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 DiabetesDiabetes Care, 2006
- Hypoglycaemic and antihyperglycaemic effects of Trigonella foenum-graecum leaf in normal and alloxan induced diabetic ratsJournal of Ethnopharmacology, 1997